Materiały źródłowe

• #1 Patients with Claudication | Society for Vascular Surgery

  https://vascular.org/patients-and-referring-physicians/referring-physicians/who-refer/patients-claudication

  Claudication is defined as leg pain with walking that is relieved by rest. […] Initial management of Claudication consists of lifestyle modification, smoking cessation, targeted medical management, and exercise therapy. […] Patients should be referred to a vascular surgeon when their symptoms are severe or progress. […] Individuals whose lifestyle is limited due to Claudication may be candidates for intervention. […] Early referral and collaboration with a vascular surgeon can lead to better outcomes for each patient. […] Recommendations for the management of patients with symptoms of Claudication: While symptomatic patients should also be counseled to stop smoking, additional treatment strategies include: Patients should be prescribed an anti-platelet agent and a statin. First-line therapy should consist of a supervised exercise program with walking a minimum of three times per week (30-60 min/session) for at least 12 weeks. Early referral to a vascular surgeon is encouraged for initial management as well as consideration of revascularization based on the patients response to noninvasive therapies.

• #2 Claudication: Causes, Symptoms And Treatment

  https://www.netmeds.com/health-library/post/claudication-causes-symptoms-and-treatment?srsltid=AfmBOoq8hoGBC3z3V3nHOpull52bE6pY2dWOq5cx9z12bg8TzmSOdUAU

  The main aim of the treatment is to lower the risk of vascular disease, mitigate pain, improve mobility, and avert tissue damage. […] The main aim of treatment is to mitigate the pain and manage risk factors that contribute to heart and blood vessel disease. […] Certain exercises are recommended as the primary part of treatment. Exercise lessens pain, increases duration, promotes vascular health in the affected limbs, and impacts weight management and the overall betterment of life. […] A guided exercise program is suggested for starting the treatment, however, long-term exercise at home is vital for continuing the management of the condition. […] The physician may prescribe one or more medications to manage pain and risk factors for heart disease. […] Surgery is often suggested when peripheral artery disease is more serious and other treatment options dont help. Angioplasty and vascular surgery are usually recommended by the doctor.

• #3 Management of symptomatic peripheral artery disease: Claudication – UpToDate

  https://www.uptodate.com/contents/management-of-claudication-due-to-peripheral-artery-disease

  Management of symptomatic peripheral artery disease: Claudication […] The general management of the patient with claudication due to PAD is reviewed. […] The management of exertional leg pain from other causes of arterial obstruction (eg, aneurysm thrombosis, embolism), arterial compression (eg, popliteal entrapment syndrome), or musculoskeletal disorders (eg, lumbar spine stenosis, adductor bursitis, spine or hip osteoarthritis) differs from PAD. […] The following limb outcomes at five years demonstrate the overall low risk of progression for most patients with lower extremity claudication: Stable claudication – 70 to 80 percent. […] Algorithm for the management of claudication […] Benefit of supervised exercise therapy in claudication.

• #4 Intermittent Claudication – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK430778/

  The guiding principle of treatment for intermittent claudication is that around 1% to 2% of patients with claudication ever progress to limb-threatening ischemia. Under this pretense, initial aggressive treatment strategies are discouraged. Most patients with intermittent claudication can be treated with medical interventions. […] Medical management includes smoking cessation, antiplatelet agents, statin therapy, blood pressure modification, glucose control, structured walking programs, and cilostazol. Structured walking programs improve pain-free walking distance better than pharmacologic therapy alone. It is important to note that continued smoking with walking therapy restricts improvement in these patients. A three-month trial of smoking cessation, ambulation, and cilostazol is typically prescribed.

• #5 A Primary Care Approach to the Patient with Claudication | AAFP

  https://www.aafp.org/pubs/afp/issues/2000/0215/p1027.html

  Patients with intermittent claudication should receive conservative treatment. Aggressive risk factor modification, smoking cessation, antiplatelet therapy and a walking program are essential. […] Walking improves the symptoms of claudication in several ways. The muscle can better adapt to anaerobic metabolism with repeated exposure to an ischemic environment. […] Pentoxifylline (Trental) is approved for the treatment of intermittent claudication. […] The newest agent for treating intermittent claudication is cilostazol (Pletal). Cilostazol is a phosphodiesterase inhibitor that suppresses platelet aggregation and acts as a direct arterial vasodilator. […] Identifying the patient with intermittent claudication is highly important. Successful management of the disease involves aggressive risk factor modification, antiplatelet therapy and an exercise program.

• #6 Current Management of Intermittent Claudication

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10773527/

  The initial treatment of intermittent claudication focuses on medical optimization of comorbid conditions, aspirin, and statin therapy, smoking cessation, and supervised exercise therapy (SET) for all patients able to participate. […] Second-line therapy involves the initiation of cilostazol in eligible patients which, when combined SET, can help augment peripheral collateral networks to reduce symptom burden. […] Once medically optimized, the third-line treatment of those patients who fail to improve after SET may include revascularization in select patients. […] SET therapy has been established in multiple societal guidelines as the first-line therapy for intermittent claudication. […] The SET strategy for treating intermittent claudication was studied in The Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study, which compared optimal medical therapy (antiplatelet and cilostazol) versus optimal medical therapy plus SET versus optimal medical therapy plus revascularization by stenting in patients with aortoiliac disease and claudication.

• #7 Treatment for Intermittent Claudication | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/intermittent-claudication/treatments.html

  Treatment for intermittent claudication may include one or more of the following: […] Intermittent claudication is usually treated conservatively, with the primary goal of treatment being modification of risk factors. […] For advanced cases in which pain is severe and/or blood flow has been completely or almost completely blocked, an invasive procedure such as angioplasty (a catheter is used to create a larger opening in the vessel to increase blood flow), stent placement (a tiny coil is expanded inside the blocked artery to open the blocked area and is left in place to keep the artery open), or surgery may be needed to open the blocked artery. […] In a small percentage of cases where all other treatments have not been effective, amputation of the affected limb may be necessary. […] A prevention plan for intermittent claudication may also be used to prevent or lessen the progress of PAD associated with intermittent claudication once it has been diagnosed.

• #8

  https://www.nhs.uk/conditions/peripheral-arterial-disease-pad/

  PAD is largely treated through lifestyle changes and medication. […] Exercising regularly and not smoking are the main lifestyle changes that can ease the symptoms of PAD and reduce the chances of it getting worse. […] The underlying causes should also be treated, including high blood pressure, high cholesterol and diabetes. Medicine and, in some cases, surgery can be used to improve the blood flow in your legs. […] With treatment, most people’s symptoms remain stable and some people may experience an improvement in their pain.

• #9 Claudication: Symptoms, causes, and treatments

  https://www.medicalnewstoday.com/articles/326553

• #10 Pinellas Vascular – Trusted Care for PAD, Claudication & Lower Leg Pain

  https://pinellasvascular.com/vascular-care-serving-tampa-bay/claudication-lower-leg-pain/

  We can diagnose and treat pain in the calf and thighs. […] Most patients with claudication do not need surgery. The first line of treatment is risk-factor modification. Patients who are above their ideal weight will frequently be able to walk farther simply by losing excess pounds. Cessation of cigarette smoking will prevent progression of arterial blockage and can improve walking distance. Control of diabetes, hypertension and elevated lipids frequently requires drug therapy managed by your primary physician. Exercise alone is an effective form of therapy. Studies have shown that a supervised exercise program, such as found at some hospitals, can significantly improve walking. […] The next line of therapy is drug treatment. Cilostazol, or Pletal, significantly improves the walking distance in 50-60% of patients.

• #11 Claudication: Symptoms, causes, and treatments

  https://www.medicalnewstoday.com/articles/326553

• #12 Intermittent Claudication – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK430778/

  Patients with intermittent claudication must be advised to eat a healthy diet, control the blood sugars and hypertension, lower the levels of cholesterol and glucose, and participate in an exercise program. There is ample evidence showing that undertaking these measures improves the quality of life and reduces the burden of many medical disorders. […] The latest data suggest that in patients with intermittent claudication, endovascular surgery, open surgery, and exercise therapy are superior to medical management in terms of walking distance and symptom relief.

• #13 Exercise therapy for intermittent claudication in peripheral artery disease

  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-13/exercise-therapy-for-intermittent-claudication-in-peripheral-artery-disease

  Exercise therapy benefits patients with intermittent claudication by reducing limb symptoms and improving both physical activity and quality of life. […] Supervised exercise programs have been recommended as first-line therapies for the treatment of claudication in patients with PAD. […] The treatment goals are: (1) to reduce limb symptoms, (2) to improve exercise capacity and prevent or lessen physical disability, and (3) to reduce the occurrence of cardiovascular events. […] Claudication significantly affects quality of life and is associated with severe functional impairment that can be significantly improved by exercise intervention in properly selected patients. […] A considerable body of evidence supports the clinical benefits of a supervised exercise program in improving exercise performance and quality of life.

• #14 Exercise therapy in intermittent claudication

  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-16/Exercise-therapy-in-intermittent-claudication

  Exercise therapy is a cornerstone in the management of intermittent claudication; supervised walking exercise three times a week over 12 weeks improves walking ability and quality of life. […] If the goal is to offer best medical therapy to these patients, healthcare professionals must recommend and refer to structured, supervised exercise programmes, which must be made available both in community health services and at the hospitals. […] Exercise training reduces symptoms in patients by increasing fitness, elevating pain thresholds, improving quality of life and preventing further disease progression. […] In the recently published ESC Guidelines for diagnosis and treatment of peripheral arterial disease, supervised exercise therapy is strongly recommended (IA) in patients with IC, both as primary treatment and after any intervention.

• #15 Exercise therapy for intermittent claudication in peripheral artery disease

  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-13/exercise-therapy-for-intermittent-claudication-in-peripheral-artery-disease

  The ESC, AHA/ACC, and Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC II) have all declared that the evidence supporting exercise therapy in the treatment of claudication is sufficiently robust to merit a Level I recommendation. […] We recommend as first-line therapy a supervised exercise program consisting of walking a minimum of three times per week (30-60 min/session) for at least 12 weeks to all suitable patients with IC. […] We recommend home-based exercise, with a goal of at least 30 minutes of walking three to five times per week when a supervised exercise program is unavailable or for long-term benefit after a supervised exercise program is completed. […] In patients who have undergone revascularization therapy for IC, we recommend exercise (either supervised or home based) for adjunctive functional benefits.

• #16 Exercise therapy for intermittent claudication in peripheral artery disease

  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-13/exercise-therapy-for-intermittent-claudication-in-peripheral-artery-disease

  The ESC, AHA/ACC, and Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC II) have all declared that the evidence supporting exercise therapy in the treatment of claudication is sufficiently robust to merit a Level I recommendation. […] We recommend as first-line therapy a supervised exercise program consisting of walking a minimum of three times per week (30-60 min/session) for at least 12 weeks to all suitable patients with IC. […] We recommend home-based exercise, with a goal of at least 30 minutes of walking three to five times per week when a supervised exercise program is unavailable or for long-term benefit after a supervised exercise program is completed. […] In patients who have undergone revascularization therapy for IC, we recommend exercise (either supervised or home based) for adjunctive functional benefits.

• #17 Exercise training for intermittent claudication: a narrative review and summary of guidelines for practitioners | BMJ Open Sport & Exercise Medicine

  https://bmjopensem.bmj.com/content/6/1/e000897

  A structured programme should involve walking at an intensity that elicits moderate-to-strong claudication pain and should be conducted for a minimum of 3 months, involving at least three sessions of 30-45 min/week. […] Current recommendations are if patients can tolerate, then walking to moderate pain (i.e 4-5 on the claudication scale) may be suitable. If patients are unable to tolerate higher levels of pain on the claudication scale, then they can walk to low levels of pain, provided the volume of exercise is sufficient, which may improve adherence levels.

• #18 Exploring treatment options for intermittent claudication | Lower Extremity Review Magazine

  https://lermagazine.com/article/exploring-treatment-options-for-intermittent-claudication

  Angioplasty plus exercise is better than either individual therapy, said Mary McDermott. […] The more time that has passed since your procedure, the more common is restenosis. […] With the exercise, you dont get immediate relief, but if you stick with it, at four to six weeks youll start seeing benefit. […] I think whether stenting adds anything to supervised exercise is still unanswered, Murphy said. […] But they should also get an exercise program, and the combination is one of the best approaches.

• #19 Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program

  https://effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol

  Two additional RCTs have been completed since the Watson et al. and Wilson reviews and suggested that endovascular revascularization plus exercise training is superior to exercise training alone with regard to maximum walking distance. In the OBACT (Oslo balloon angioplasty versus conservative treatment) trial, patients in the combined arm showed an improvement in maximum walking distance with the addition of angioplasty to exercise. The MIMIC (mild to moderate IC) trial found that, PTA against a background of supervised exercise and best medical therapy was superior to supervised exercise and medical therapy alone with respect to maximum walking distance and ABI at 2 years. Importantly, endovascular intervention in the OBACT and MIMIC trials was primarily confined to the aortoiliac and femoropopliteal areas. In addition, the CLEVER (claudication: exercise versus endoluminal revascularization) trial—a National Institutes of Health-sponsored small, randomized trial studying optimal medical therapy versus supervised exercise therapy versus endovascular revascularization—has recently published 6-month outcome data. In this cohort of patients with aortoiliac disease, supervised exercise therapy improved peak walking time and patient-reported quality of life over optimal medical therapy. Notably, while peak walking time showed greater improvement in supervised exercise therapy versus stenting, stenting was superior in improving patient-reported quality of life.

• #20 Exercise therapy for intermittent claudication in peripheral artery disease

  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-13/exercise-therapy-for-intermittent-claudication-in-peripheral-artery-disease

  The ESC, AHA/ACC, and Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC II) have all declared that the evidence supporting exercise therapy in the treatment of claudication is sufficiently robust to merit a Level I recommendation. […] We recommend as first-line therapy a supervised exercise program consisting of walking a minimum of three times per week (30-60 min/session) for at least 12 weeks to all suitable patients with IC. […] We recommend home-based exercise, with a goal of at least 30 minutes of walking three to five times per week when a supervised exercise program is unavailable or for long-term benefit after a supervised exercise program is completed. […] In patients who have undergone revascularization therapy for IC, we recommend exercise (either supervised or home based) for adjunctive functional benefits.

• #21 Exercise therapy in intermittent claudication

  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-16/Exercise-therapy-in-intermittent-claudication

  Supervised exercise therapy has previously been shown to be statistically significantly effective in improving maximal walking distance or maximal walking time compared to unsupervised exercise. […] Home-based supervised exercise may improve maximal and pain-free walking distance compared to just giving advice about exercise, but was less effective than hospital-based supervised exercise. […] Patients with IC are at increased risk of cardiovascular events, and concern about safety during exercise has questioned the need for cardiac screening before entering an exercise programme. […] Supervised walking exercise is a safe and evidence-based treatment in patients with IC, but few patients exercise according to guidelines. […] Exercise prevents disease progression, increases fitness, elevates the pain threshold and improves quality of life. […] Alternative and less painful exercise modes than walking can improve symptoms and walking ability, and should be further investigated in the future. […] Use of new technology needs to be implemented in clinical practice in order to provide supervised home-based exercise for patients with IC.

• #22 Current Management of Intermittent Claudication

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10773527/

  The initial treatment of intermittent claudication focuses on medical optimization of comorbid conditions, aspirin, and statin therapy, smoking cessation, and supervised exercise therapy (SET) for all patients able to participate. […] Second-line therapy involves the initiation of cilostazol in eligible patients which, when combined SET, can help augment peripheral collateral networks to reduce symptom burden. […] Once medically optimized, the third-line treatment of those patients who fail to improve after SET may include revascularization in select patients. […] SET therapy has been established in multiple societal guidelines as the first-line therapy for intermittent claudication. […] The SET strategy for treating intermittent claudication was studied in The Claudication: Exercise Versus Endoluminal Revascularization (CLEVER) Study, which compared optimal medical therapy (antiplatelet and cilostazol) versus optimal medical therapy plus SET versus optimal medical therapy plus revascularization by stenting in patients with aortoiliac disease and claudication.

• #23 Current Management of Intermittent Claudication

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10773527/

  Because of this and multiple other high-quality studies showing improved patient outcomes, SET is now considered standard of care for first-line therapy of intermittent claudication. […] Current professional guidelines suggest that patients be treated for intermittent claudication using a conservative approach (meaning first-line and second-line therapies as described above) for a minimum of 3 to 6 months before consideration of revascularization. […] Revascularization in patients with intermittent claudication should be reserved for patients with lifestyle-limiting symptoms who are fully optimized on medical therapy and have had comprehensive risk factor mitigation, including completion of SET or a home walking program for a minimum of 3 to 6 months. […] Claudication is associated with significant cardiovascular risk but low risk of limb loss and is best initially managed by medical optimization, smoking cessation, daily aspirin, statin therapy, and SET. […] Additional interventions may be considered in those who complete first-line therapy and remain symptomatic, including consideration of cilostazol (second-line therapy) and revascularization (third-line therapy).

• #24 Cilostazol for Intermittent Claudication Caused by Peripheral Artery Disease | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p366.html

  Cilostazol improves initial and absolute walking distances in patients with intermittent claudication secondary to PAD and appears to be equivalent in effect to pentoxifylline. […] Medications used to treat intermittent claudication include pentoxifylline (a hemorheologic agent that helps improve blood flow through narrow arteries), antiplatelet agents, and anticoagulants. […] Patients taking cilostazol demonstrated an increased initial claudication distance vs. those taking placebo (mean difference = 26 m; 95% CI, 19 to 34 m; low-certainty evidence). […] Patients taking cilostazol also had an increased absolute claudication distance compared with placebo (mean difference = 40 m; 95% CI, 22 to 57 m; very low-certainty evidence). […] The evidence was insufficient to draw conclusions about the effect of cilostazol on quality of life or other outcomes such as rates of revascularization, cardiovascular events, or amputation.

• #25 A Primary Care Approach to the Patient with Claudication | AAFP

  https://www.aafp.org/pubs/afp/issues/2000/0215/p1027.html

  Patients with intermittent claudication should receive conservative treatment. Aggressive risk factor modification, smoking cessation, antiplatelet therapy and a walking program are essential. […] Walking improves the symptoms of claudication in several ways. The muscle can better adapt to anaerobic metabolism with repeated exposure to an ischemic environment. […] Pentoxifylline (Trental) is approved for the treatment of intermittent claudication. […] The newest agent for treating intermittent claudication is cilostazol (Pletal). Cilostazol is a phosphodiesterase inhibitor that suppresses platelet aggregation and acts as a direct arterial vasodilator. […] Identifying the patient with intermittent claudication is highly important. Successful management of the disease involves aggressive risk factor modification, antiplatelet therapy and an exercise program.

• #26 Cilostazol for Intermittent Claudication Caused by Peripheral Artery Disease | AAFP

  https://www.aafp.org/pubs/afp/issues/2022/0400/p366.html

  Cilostazol improves initial and absolute walking distances in patients with intermittent claudication secondary to PAD and appears to be equivalent in effect to pentoxifylline. […] Medications used to treat intermittent claudication include pentoxifylline (a hemorheologic agent that helps improve blood flow through narrow arteries), antiplatelet agents, and anticoagulants. […] Patients taking cilostazol demonstrated an increased initial claudication distance vs. those taking placebo (mean difference = 26 m; 95% CI, 19 to 34 m; low-certainty evidence). […] Patients taking cilostazol also had an increased absolute claudication distance compared with placebo (mean difference = 40 m; 95% CI, 22 to 57 m; very low-certainty evidence). […] The evidence was insufficient to draw conclusions about the effect of cilostazol on quality of life or other outcomes such as rates of revascularization, cardiovascular events, or amputation.

• #27

  https://www.vascularsurg.com/claudication/

  Once the diagnosis of intermittent claudication has been clearly established, the first line of treatment is risk-factor modification. Patients who are above their ideal weight will frequently be able to walk farther simply by losing excess pounds. Cessation of cigarette smoking will prevent progression of arterial blockage and can improve walking distance. Control of diabetes, hypertension and elevated lipids frequently requires drug therapy managed by your primary physician. Exercise alone is an effective form of therapy. Studies have shown that a supervised exercise program, such as found at some hospitals, can significantly improve walking. The next line of therapy is drug treatment. Cilostazol, or Pletal, significantly improves the walking distance in 50-60% of patients. This medication interacts with some drugs and should NOT be given if you have known congestive heart failure. It takes 2-3 months to determine whether you are responding to Pletal. Common side effects are diarrhea, headache and palpitations.

• #28 Patients with Claudication – The Society for Vascular Medicine

  https://myperipheralarterydisease.com/health-care-providers/medical-therapy/patients-with-claudication/

  The next step in guiding medical therapy is considering whether the patient is symptomatic. Two therapies are approved to reduce symptoms of claudication in PAD: cilostazol and pentoxifylline. Cilostazol appears to be effective but pentoxifylline provides little to no benefit. Cilostazol should be offered to patients who have lifestyle-limiting symptoms. In general, it has a favorable safety profile; however, some patients have gastrointestinal side effects. In addition, due to risks observed with other agents in this class, it should not be given to patients with heart failure.

• #29 Treatment of Intermittent Claudication

  https://www.medscape.com/viewarticle/406951

  The pathophysiology of intermittent claudication (IC) and the role of pentoxifylline and cilostazol for treating IC are discussed. […] Cilostazol and pentoxifylline are the only two drugs with FDA-approved labeling for use in treating IC. Both drugs have been shown to increase pain-free walking time and total distance walked, although there is some conflicting evidence for pentoxifylline. […] The mainstays of therapy for IC are risk-factor modification, exercise, and antiplatelet therapy. If these prove inadequate, treatment with pentoxifylline or cilostazol may be reasonable. […] This article reviews the pathophysiology of IC and the efficacy and safety of treatment options for IC, specifically pentoxifylline and cilostazol.

• #30 Patients with Claudication – The Society for Vascular Medicine

  https://myperipheralarterydisease.com/health-care-providers/medical-therapy/patients-with-claudication/

  The next step in guiding medical therapy is considering whether the patient is symptomatic. Two therapies are approved to reduce symptoms of claudication in PAD: cilostazol and pentoxifylline. Cilostazol appears to be effective but pentoxifylline provides little to no benefit. Cilostazol should be offered to patients who have lifestyle-limiting symptoms. In general, it has a favorable safety profile; however, some patients have gastrointestinal side effects. In addition, due to risks observed with other agents in this class, it should not be given to patients with heart failure.

• #31 Claudication: Symptoms, causes, and treatments

  https://www.medicalnewstoday.com/articles/326553

• #32 Intermittent Claudication – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK430778/

  The guiding principle of treatment for intermittent claudication is that around 1% to 2% of patients with claudication ever progress to limb-threatening ischemia. Under this pretense, initial aggressive treatment strategies are discouraged. Most patients with intermittent claudication can be treated with medical interventions. […] Medical management includes smoking cessation, antiplatelet agents, statin therapy, blood pressure modification, glucose control, structured walking programs, and cilostazol. Structured walking programs improve pain-free walking distance better than pharmacologic therapy alone. It is important to note that continued smoking with walking therapy restricts improvement in these patients. A three-month trial of smoking cessation, ambulation, and cilostazol is typically prescribed.

• #33 Claudication: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/21972-claudication

  Your provider may prescribe medications that: Lower your blood pressure (like ACE inhibitors), Lower your cholesterol (like statins), Lower your blood sugar level (like insulin), Prevent clotting to increase blood flow (like aspirin or clopidogrel), Open your arteries (like cilostazol). […] If medicines don’t work, your provider may want to do a minimally invasive treatment. They may use angioplasty to treat a narrow or blocked artery by using a catheter. A provider may also put a stent into an artery they open to help it stay that way. Another option is bypass surgery to reroute blood flow. Providers only use surgery in severe cases. […] Treatment for claudication gives many people a good prognosis (outlook). But it’s important to remember that peripheral artery disease (which causes claudication) is a lifelong condition. PAD progresses faster in some people than others. The expected length of your life depends on your specific situation. This includes any other diseases you have.

• #34

  https://www.nhs.uk/conditions/peripheral-arterial-disease-pad/treatment/

  You may be offered naftidrofuryl oxalate if you have leg pain triggered by exercise (intermittent claudication). […] This medicine may improve blood flow in the body, and is very occasionally used if you prefer not to have surgery. […] In a few cases, a procedure to restore the flow of blood through the arteries in your legs may be recommended. […] Revascularisation may be recommended if your leg pain is so severe it prevents you from carrying out everyday activities, or if your symptoms have failed to respond to the treatments mentioned.

• #35 Current Management of Intermittent Claudication

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10773527/

  Because of this and multiple other high-quality studies showing improved patient outcomes, SET is now considered standard of care for first-line therapy of intermittent claudication. […] Current professional guidelines suggest that patients be treated for intermittent claudication using a conservative approach (meaning first-line and second-line therapies as described above) for a minimum of 3 to 6 months before consideration of revascularization. […] Revascularization in patients with intermittent claudication should be reserved for patients with lifestyle-limiting symptoms who are fully optimized on medical therapy and have had comprehensive risk factor mitigation, including completion of SET or a home walking program for a minimum of 3 to 6 months. […] Claudication is associated with significant cardiovascular risk but low risk of limb loss and is best initially managed by medical optimization, smoking cessation, daily aspirin, statin therapy, and SET. […] Additional interventions may be considered in those who complete first-line therapy and remain symptomatic, including consideration of cilostazol (second-line therapy) and revascularization (third-line therapy).

• #36 Current Management of Intermittent Claudication

  https://pmc.ncbi.nlm.nih.gov/articles/PMC10773527/

  Because of this and multiple other high-quality studies showing improved patient outcomes, SET is now considered standard of care for first-line therapy of intermittent claudication. […] Current professional guidelines suggest that patients be treated for intermittent claudication using a conservative approach (meaning first-line and second-line therapies as described above) for a minimum of 3 to 6 months before consideration of revascularization. […] Revascularization in patients with intermittent claudication should be reserved for patients with lifestyle-limiting symptoms who are fully optimized on medical therapy and have had comprehensive risk factor mitigation, including completion of SET or a home walking program for a minimum of 3 to 6 months. […] Claudication is associated with significant cardiovascular risk but low risk of limb loss and is best initially managed by medical optimization, smoking cessation, daily aspirin, statin therapy, and SET. […] Additional interventions may be considered in those who complete first-line therapy and remain symptomatic, including consideration of cilostazol (second-line therapy) and revascularization (third-line therapy).

• #37 Treatment for Intermittent Claudication | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/intermittent-claudication/treatments.html

  Treatment for intermittent claudication may include one or more of the following: […] Intermittent claudication is usually treated conservatively, with the primary goal of treatment being modification of risk factors. […] For advanced cases in which pain is severe and/or blood flow has been completely or almost completely blocked, an invasive procedure such as angioplasty (a catheter is used to create a larger opening in the vessel to increase blood flow), stent placement (a tiny coil is expanded inside the blocked artery to open the blocked area and is left in place to keep the artery open), or surgery may be needed to open the blocked artery. […] In a small percentage of cases where all other treatments have not been effective, amputation of the affected limb may be necessary. […] A prevention plan for intermittent claudication may also be used to prevent or lessen the progress of PAD associated with intermittent claudication once it has been diagnosed.

• #38 Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program

  https://effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol

  3. Revascularization […] Historically, patients with IC have been treated conservatively for their leg symptoms with medical therapy, lifestyle modification, and exercise programs because of the low overall risk of limb-threatening ischemia. Multiple strategies for revascularization include surgery, angioplasty (cryoplasty, drug-coated, cutting, and standard angioplasty balloons are available for use in peripheral arteries), stenting (self-expanding and balloon-expandable stents are available, but drug-eluting stents are not currently approved for treating peripheral arteries in the United States), and atherectomy (laser, directional, orbital, and rotational atherectomy devices are approved for use in the United States). With improvements in endovascular techniques and equipment, the use of balloon angioplasty, stenting, and atherectomy has led to application of endovascular revascularization to a wider range of patients over the past decade, both among those with more severe symptoms and those with less severe symptoms. Goals for treating IC with invasive therapies are to improve leg pain, walking distance, and quality of life. Decisions about whether to revascularize and how to revascularize patients with PAD depend on a number of factors, including patient-specific characteristics, anatomic location, severity of symptoms, need for possible repeat revascularization in the future, and patient and physician preferences. Clinical guidelines remain vague regarding the absolute indications for and appropriate use of revascularization strategies in patients with PAD. Clinical uncertainty exists around whether strategies of optimal medical therapy and exercise training with or without revascularization are better. Once clinicians have decided on a revascularization strategy, further uncertainty exists around the type of revascularization (i.e., endovascular vs. surgical).

• #39 Claudication – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/claudication/diagnosis-treatment/drc-20370959

  When peripheral artery disease is severe and other treatments don’t work, surgery may be required. Options include: […] This procedure improves blood flow by widening a damaged artery. […] During this type of surgery, a surgeon takes a healthy blood vessel from another part of the body to replace the vessel that’s causing claudication.

• #40 Claudication Treatment | The Vascular Care Group

  https://thevascularcaregroup.com/our-services/arterial-treatments/claudication/

  Treatments typically focuses on lowering the risks of vascular disease, reducing pain, increasing mobility and preventing damage to tissues. […] The goals of treating claudication and PAD are to reduce pain and manage the risk factors. […] Exercise is an important part of treatment; it reduces pain, increases exercise duration, improves vascular health in the affected limbs, and contributes to weight management and an improvement in quality of life. […] Supervised exercise is recommended for beginning the treatment, but long-term exercise at home is important for ongoing management of claudication. […] Medications may be used to manage the following: Pain, High cholesterol, High blood pressure, Other cardiovascular risks. […] When PAD is severe and other treatments dont work, surgery may be required. Options include: Endovascular Procedures including possible angioplasty, atherectomy, or stent. This procedure improves blood flow by widening a damage artery. A surgeon guides a wire and then a device through the blood vessels. The devices may soften the blockage before inflating a balloon and/or placing a stent to keep the vessel open. […] Bypass surgery. During this type of surgery, a surgeon takes a healthy blood vessel from another part of the body to replace the vessel thats causing claudication. This allows blood to flow around the blocked artery.

• #41 Intermittent Claudication: Symptoms & Treatment

  https://my.clevelandclinic.org/health/symptoms/22046-intermittent-claudication

  Surgery or minimally invasive procedures Procedures to restore blood flow may relieve or reduce the pain from intermittent claudication. Possible procedures include the following: Angioplasty: This is a minimally invasive procedure that uses a catheter to widen the artery. […] Claudication increases your risk for serious heart and circulatory problems. This is why treatment usually involves preventive measures to avoid those complications. […] Many of the at-home treatments for intermittent claudication can also help prevent it. While its not always possible to prevent it completely, it may be possible to delay when it develops. […] If you have intermittent claudication, early diagnosis and treatment can help you avoid or limit serious problems in the future.

• #42 Treatment for Intermittent Claudication | Stanford Health Care

  https://stanfordhealthcare.org/medical-conditions/blood-heart-circulation/intermittent-claudication/treatments.html

  Treatment for intermittent claudication may include one or more of the following: […] Intermittent claudication is usually treated conservatively, with the primary goal of treatment being modification of risk factors. […] For advanced cases in which pain is severe and/or blood flow has been completely or almost completely blocked, an invasive procedure such as angioplasty (a catheter is used to create a larger opening in the vessel to increase blood flow), stent placement (a tiny coil is expanded inside the blocked artery to open the blocked area and is left in place to keep the artery open), or surgery may be needed to open the blocked artery. […] In a small percentage of cases where all other treatments have not been effective, amputation of the affected limb may be necessary. […] A prevention plan for intermittent claudication may also be used to prevent or lessen the progress of PAD associated with intermittent claudication once it has been diagnosed.

• #43 Intermittent claudication – Wikipedia

  https://en.wikipedia.org/wiki/Intermittent_claudication

  Exercise can improve symptoms, as can revascularization. Both together may be better than one intervention of its own. […] Supervised exercise improves maximum walking distance and pain-free walking distance more than home based exercise. Although when monitoring is included in home based exercise programmes similar changes in pain-free walking distance are observed in both supervised and home based exercise. […] In people with stable leg pain, exercise, such as strength training, pole-striding and upper or lower limb exercises, compared to usual care or placebo improves maximum walking time, pain-free walking distance and maximum walking distance. […] Pharmacological options exist, as well. Medicines that control lipid profile, diabetes, and hypertension may increase blood flow to the affected muscles and allow for increased activity levels. Angiotensin converting enzyme inhibitors, adrenergic agents such as alpha-1 blockers and beta-blockers and alpha-2 agonists, antiplatelet agents (aspirin and clopidogrel), naftidrofuryl, pentoxifylline, and cilostazol (selective PDE3 inhibitor) are used for the treatment of intermittent claudication. However, medications will not remove the blockages from the body. Instead, they simply improve blood flow to the affected area.

• #44 Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program

  https://effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol

  Anatomic location may help determine the preferable revascularization strategy (endovascular vs. surgical); however, this topic remains controversial. The Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease provides some guidance for the revascularization strategy based on anatomic location and severity. In general, in patients with stenosis of the aortoiliac segments, balloon angioplasty and stenting compare favorably with surgical patency rates while dramatically lowering the periprocedural mortality risk. However, there is still uncertainty about the most effective revascularization strategy in patients with femoropopliteal stenosis. Multiple trials are currently comparing exercise therapy, angioplasty with or without stenting, and surgical revascularization. While improved clinical outcomes have been reported with angioplasty and stenting when compared to medical therapy, the longevity of results in the femoropopliteal segment remains a concern. Tibioperoneal, or below-knee, endovascular interventions are typically reserved for patients with limb-threatening ischemia; however, multiple reports describe the adoption of tibioperoneal intervention for severe claudication.

• #45 Peripheral artery disease and intermittent claudication Information | Mount Sinai – New York

  https://www.mountsinai.org/health-library/report/peripheral-artery-disease-and-intermittent-claudication

  Exercise training improves blood flow in the legs and, in some cases, can work as well as medications and surgical procedures in increasing pain-free walking distance. […] Cilostazol (Pletal, generic) is used to treat disabling intermittent claudication. A number of studies have reported that the drug helps improve walking distance and quality of life. […] In severe cases of PAD, surgery may be needed to open blocked blood vessels. Many different types of surgical procedures can be performed. They include open bypass procedures, which connect an artery before the location of the obstruction to an artery below the obstruction, or minimally invasive endovascular techniques such as angioplasty and stenting. […] Surgery is generally performed for claudication that has become disabling despite full medical and exercise therapy.

• #46 Claudication – Diagnosis & treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/claudication/diagnosis-treatment/drc-20370959

  When peripheral artery disease is severe and other treatments don’t work, surgery may be required. Options include: […] This procedure improves blood flow by widening a damaged artery. […] During this type of surgery, a surgeon takes a healthy blood vessel from another part of the body to replace the vessel that’s causing claudication.

• #47 Peripheral Arterial Disease and Claudication

  https://familydoctor.org/condition/peripheral-arterial-disease-and-claudication/

  If your arteries are badly blocked, you may need a procedure called angioplasty to open them up. During an angioplasty, a thin tube called a catheter is inserted into the artery. A small balloon on the tip of the catheter is inflated. This helps to open up the artery. The balloon is then deflated and removed. Sometimes a device called a stent (a small wire mesh tube) will be left in the artery. The stent will help hold the artery open. Angioplasty is normally done while you are awake. […] If the narrow area of the artery is very long, you may need to have bypass surgery. For the surgery, your doctor will take a vein from another part of your body. The vein will be attached above and below the narrowed part of the artery. This lets the blood flow around the narrowed area. Sometimes a synthetic (manmade) graft is used instead of a vein. […] Treatment and lifestyle changes such as diet and exercise can improve PAD symptoms. They can also decrease your likelihood for heart attack or stroke.

• #48 Peripheral Arterial Occlusive Disease Treatment & Management: Approach Considerations, Smoking Cessation, Pharmacologic Therapy

  https://emedicine.medscape.com/article/460178-treatment

  Treatment of claudication is medical, except in severe cases. The goal of medical management of peripheral arterial occlusive disease (PAOD) is to impede the progression of the disease. This may include both pharmacologic and nonpharmacologic measures. For patients in whom medical and exercise therapy fail or those who have lifestyle-limiting claudication symptoms, surgical treatment options are the next line of therapy. […] As noted in SVS guidelines for management of claudication, numerous randomized trials have documented modest improvements in walking distance in pentoxifylline treatment groups as compared with placebo treatment groups. Treatment may take as long as 2-3 months to produce noticeable results. […] Surgical treatment options, typically reserved for patients with more severe disease or those in whom nonsurgical management fails, include the following: Open bypass surgery, Endovascular therapy (eg, stenting, balloon angioplasty, or atherectomy).

• #49 Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program

  https://effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol

  Patient characteristics such as advanced age, concomitant coronary artery disease or heart failure, and ongoing tobacco use often influence clinical decision-making and can make surgical revascularization unfavorable in patients for whom general anesthesia is risky. Endovascular revascularization offers multiple distinct advantages over surgical procedures. These advantages include the use of local anesthesia rather than general anesthesia, short recovery times, and reduced short-term morbidity and mortality. Critics of endovascular intervention cite the shorter duration of improvement and the need for and cost of repeat revascularization procedures as disadvantages. The introduction of hybrid revascularization techniques (endovascular and surgical revascularization performed in the same setting or with a staged approach) presents the potential advantage of combining the durability of surgical revascularization with the lower procedural risk of endovascular therapies.

• #50 Shockwave Therapy Shows Benefit in Lower Limb Claudication | MedPage Today

  https://www.medpagetoday.com/cardiology/peripheralarterydisease/109608

  Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little benefit from that standard first-line approach, a randomized trial suggested. […] Furthermore, the shockwave group had significantly greater improvements at this time point in pain-free walking distance (median 34.1 meters, 95% CI 11.4-56.8, P=0.004) and maximum walking distance (median 51.4 meters, 95% CI 10.7-86.5, P=0.01), according to findings of the single-center double-blind study published in JAMA Surgery. […] The research team nevertheless concluded that extracorporeal shockwave therapy „appears to be a potential alternative to supervised exercise for patients with intermittent claudication that can improve patient choice and increase access and engagement with noninvasive treatment.”

• #51 Intermittent Claudication: Definition, Symptoms, Treatment, and More

  https://www.healthline.com/health/intermittent-claudication

  If PAD is the cause of intermittent claudication, its treatable but not curable. Physical therapy can improve walking distance. Drugs and surgery can treat PAD and minimize its risk factors. Aggressive treatment to minimize risk factors is advised. […] Theres ongoing research to find better treatments, including gene therapy and methods for increasing new blood vessel growth (therapeutic angiogenesis). Talk to your doctor about current therapies, as well as new therapies and clinical trials.

• #52 Shockwave Therapy Shows Benefit in Lower Limb Claudication | MedPage Today

  https://www.medpagetoday.com/cardiology/peripheralarterydisease/109608

  Extracorporeal shockwave therapy may be effective for intermittent lower limb claudication in peripheral artery disease (PAD) patients unable to engage in supervised exercise or who experienced little benefit from that standard first-line approach, a randomized trial suggested. […] Furthermore, the shockwave group had significantly greater improvements at this time point in pain-free walking distance (median 34.1 meters, 95% CI 11.4-56.8, P=0.004) and maximum walking distance (median 51.4 meters, 95% CI 10.7-86.5, P=0.01), according to findings of the single-center double-blind study published in JAMA Surgery. […] The research team nevertheless concluded that extracorporeal shockwave therapy „appears to be a potential alternative to supervised exercise for patients with intermittent claudication that can improve patient choice and increase access and engagement with noninvasive treatment.”

• #53 Intermittent Claudication: Definition, Symptoms, Treatment, and More

  https://www.healthline.com/health/intermittent-claudication

  If PAD is the cause of intermittent claudication, its treatable but not curable. Physical therapy can improve walking distance. Drugs and surgery can treat PAD and minimize its risk factors. Aggressive treatment to minimize risk factors is advised. […] Theres ongoing research to find better treatments, including gene therapy and methods for increasing new blood vessel growth (therapeutic angiogenesis). Talk to your doctor about current therapies, as well as new therapies and clinical trials.

• #54 Diagnosis And Treatment Options For Claudication – Klarity Health Library

  https://my.klarity.health/diagnosis-and-treatment-options-for-claudication/

  Claudication is linked with peripheral artery disease (PAD), where plaque builds up in the arteries, restricting blood flow. […] Early detection and treatment of claudication is essential, as the condition can worsen over time, and further problems can develop. […] Treatment options for claudication can include lifestyle modifications, such as stopping smoking, diet changes, and participation in an exercise programme to develop collateral pathways. Medications also play an important role, such as antiplatelets, statins and vasodilators, to improve blood flow in the arteries. Surgical options can be useful in cases of severe disease when lifestyle changes are not enough to improve circulation. […] One novel therapy which can be used is gene therapy, which could aid in the growth of new arteries in areas with blockages or narrowings. […] Patients with claudication should have follow-up appointments to monitor treatment progress, check on medications, and determine if any further treatment will be needed, such as surgical intervention.

• #55 Intermittent Claudication | Ohio State Medical Center

  https://wexnermedical.osu.edu/heart-vascular/vascular-care/claudication

  Caring for claudication is one of many offerings for vascular care at Ohio State. […] Treatment of claudication focuses on modifying your risk factors, including: […] Many of these risk factors can be reduced or eliminated by changing your lifestyle. […] If your case is advanced and you have severe pain or almost completely blocked blood flow, you may require more invasive treatment, such as: […] In a small number of cases, when progression of the condition is not halted, amputation of the affected limb may be necessary. […] Studies are underway in the Division of Vascular Diseases and Surgery at The Ohio State University Wexner Medical Center to evaluate the use of a patients own stem cells to treat severe blockage when all other treatments are exhausted and the only alternative is amputation.

• #56 Exploring treatment options for intermittent claudication | Lower Extremity Review Magazine

  https://lermagazine.com/article/exploring-treatment-options-for-intermittent-claudication

  Angioplasty plus exercise is better than either individual therapy, said Mary McDermott. […] The more time that has passed since your procedure, the more common is restenosis. […] With the exercise, you dont get immediate relief, but if you stick with it, at four to six weeks youll start seeing benefit. […] I think whether stenting adds anything to supervised exercise is still unanswered, Murphy said. […] But they should also get an exercise program, and the combination is one of the best approaches.

• #57 Exploring treatment options for intermittent claudication | Lower Extremity Review Magazine

  https://lermagazine.com/article/exploring-treatment-options-for-intermittent-claudication

  Despite the documented benefits of supervised exercise in patients with claudication, its effect on actual clinical practice has been disappointing due to a lack of reimbursement. […] Supervised exercise is a very effective therapy for claudication, she said. It improves both walking ability and quality of life. […] Research delineates the benefits of supervised exercise for IC patients. […] Supervised exercise occupies a central role in PAD, said William Hiatt, MD, a professor of medicine in the Division of Cardiology at the University of Colorado (UC) School of Medicine in Denver. […] A recent paper by Mary McDermott supports this notion. […] These patients have so few therapeutic options open to them, and exercise works, McDermott said. […] If you really want to improve blood flow through the major arteries of the leg, revascularization is the way to do it, because exercise isnt going to diminish the arterial plaque, he said.

• #58 Exploring treatment options for intermittent claudication | Lower Extremity Review Magazine

  https://lermagazine.com/article/exploring-treatment-options-for-intermittent-claudication

  Angioplasty plus exercise is better than either individual therapy, said Mary McDermott. […] The more time that has passed since your procedure, the more common is restenosis. […] With the exercise, you dont get immediate relief, but if you stick with it, at four to six weeks youll start seeing benefit. […] I think whether stenting adds anything to supervised exercise is still unanswered, Murphy said. […] But they should also get an exercise program, and the combination is one of the best approaches.

• #59 Treatment Strategies for Patients With Peripheral Artery Disease (PAD) | Effective Health Care (EHC) Program

  https://effectivehealthcare.ahrq.gov/products/peripheral-artery-disease-treatment/research-protocol

  Two additional RCTs have been completed since the Watson et al. and Wilson reviews and suggested that endovascular revascularization plus exercise training is superior to exercise training alone with regard to maximum walking distance. In the OBACT (Oslo balloon angioplasty versus conservative treatment) trial, patients in the combined arm showed an improvement in maximum walking distance with the addition of angioplasty to exercise. The MIMIC (mild to moderate IC) trial found that, PTA against a background of supervised exercise and best medical therapy was superior to supervised exercise and medical therapy alone with respect to maximum walking distance and ABI at 2 years. Importantly, endovascular intervention in the OBACT and MIMIC trials was primarily confined to the aortoiliac and femoropopliteal areas. In addition, the CLEVER (claudication: exercise versus endoluminal revascularization) trial—a National Institutes of Health-sponsored small, randomized trial studying optimal medical therapy versus supervised exercise therapy versus endovascular revascularization—has recently published 6-month outcome data. In this cohort of patients with aortoiliac disease, supervised exercise therapy improved peak walking time and patient-reported quality of life over optimal medical therapy. Notably, while peak walking time showed greater improvement in supervised exercise therapy versus stenting, stenting was superior in improving patient-reported quality of life.

• #60 Exercise therapy for intermittent claudication in peripheral artery disease

  https://www.escardio.org/Journals/E-Journal-of-Cardiology-Practice/Volume-13/exercise-therapy-for-intermittent-claudication-in-peripheral-artery-disease

  The ESC, AHA/ACC, and Trans-Atlantic Inter-Society Consensus Document on Management of Peripheral Arterial Disease (TASC II) have all declared that the evidence supporting exercise therapy in the treatment of claudication is sufficiently robust to merit a Level I recommendation. […] We recommend as first-line therapy a supervised exercise program consisting of walking a minimum of three times per week (30-60 min/session) for at least 12 weeks to all suitable patients with IC. […] We recommend home-based exercise, with a goal of at least 30 minutes of walking three to five times per week when a supervised exercise program is unavailable or for long-term benefit after a supervised exercise program is completed. […] In patients who have undergone revascularization therapy for IC, we recommend exercise (either supervised or home based) for adjunctive functional benefits.

• #61 Management of symptomatic peripheral artery disease: Claudication – UpToDate

  https://www.uptodate.com/contents/management-of-claudication-due-to-peripheral-artery-disease

  Management of symptomatic peripheral artery disease: Claudication […] The general management of the patient with claudication due to PAD is reviewed. […] The management of exertional leg pain from other causes of arterial obstruction (eg, aneurysm thrombosis, embolism), arterial compression (eg, popliteal entrapment syndrome), or musculoskeletal disorders (eg, lumbar spine stenosis, adductor bursitis, spine or hip osteoarthritis) differs from PAD. […] The following limb outcomes at five years demonstrate the overall low risk of progression for most patients with lower extremity claudication: Stable claudication – 70 to 80 percent. […] Algorithm for the management of claudication […] Benefit of supervised exercise therapy in claudication.

• #62 Neurogenic Claudication Diagnosis & Treatment – NYC | Columbia Neurosurgery in New York City

  https://www.neurosurgery.columbia.edu/patient-care/conditions/neurogenic-claudication

  Neurogenic claudication results from compression of the spinal nerves in the lumbar (lower) spine. […] Neurogenic claudication is different from vascular claudication, sometimes simply called claudication, which is caused by impaired blood flow to the leg muscles. […] In general, the goal of surgical treatment is to decompress (remove the pressure from) the nerve roots in the lumbar spine. If the compression results from a herniated disc, a microdiscectomy (a procedure that uses small incisions with a tiny video camera for viewing) may provide relief. In other cases, a laminectomy (removal of part of a bone) may be necessary. Our surgeons can determine the best treatment for each case.

• #63 Neurogenic Claudication: Causes of Pain and Treatment

  https://www.verywellhealth.com/neurogenic-claudication-296632

  Neurogenic claudication occurs when spinal nerves get compressed in the lumbar (lower) spine, causing intermittent leg pain. […] Treatment for neurogenic claudication usually is conservative and back surgery is considered a later option. These treatment options include the following: […] Physical therapy is usually a part of the treatment plan. This includes stretches, strengthening, and aerobic exercises that can help improve posture and stabilize your lower back muscles. […] A type of back surgery known as a laminectomy can be used to decompress the lumbar spine if other treatments don’t work and symptoms significantly impact quality of life. […] The treatment of neurogenic claudication is typically conservative and may involve oral painkillers, physical therapy, occupational therapy, or, in severe cases, spinal steroid injections. Back surgery is a last resort when all other options fail.

• #64 Understandind Neurogenic Claudication – Southern Pain and Neurological

  https://southernpainclinic.com/blog/understanding-neurogenic-claudication-causes-symptoms-and-treatment/

  The treatment for neurogenic claudication will depend on the severity of the condition and the underlying cause. In many cases, conservative treatments such as physical therapy, exercise, and medications may be recommended. These treatments can help to reduce pain and improve mobility. In some cases, however, surgery may be necessary to relieve the compression on the spinal nerves. […] Conservative treatments for neurogenic claudication may include physical therapy, exercise, and medications. Physical therapy can help to strengthen the muscles in the lower back and improve flexibility, which can help to reduce pain and improve mobility. Exercise can also help to reduce pain and improve overall health. Medications such as anti-inflammatories and pain relievers can reduce pain and inflammation.

• #65 Neurogenic Claudication: Causes of Pain and Treatment

  https://www.verywellhealth.com/neurogenic-claudication-296632

  Neurogenic claudication occurs when spinal nerves get compressed in the lumbar (lower) spine, causing intermittent leg pain. […] Treatment for neurogenic claudication usually is conservative and back surgery is considered a later option. These treatment options include the following: […] Physical therapy is usually a part of the treatment plan. This includes stretches, strengthening, and aerobic exercises that can help improve posture and stabilize your lower back muscles. […] A type of back surgery known as a laminectomy can be used to decompress the lumbar spine if other treatments don’t work and symptoms significantly impact quality of life. […] The treatment of neurogenic claudication is typically conservative and may involve oral painkillers, physical therapy, occupational therapy, or, in severe cases, spinal steroid injections. Back surgery is a last resort when all other options fail.

• #66 Neurogenic Claudication Diagnosis & Treatment – NYC | Columbia Neurosurgery in New York City

  https://www.neurosurgery.columbia.edu/patient-care/conditions/neurogenic-claudication

  Neurogenic claudication results from compression of the spinal nerves in the lumbar (lower) spine. […] Neurogenic claudication is different from vascular claudication, sometimes simply called claudication, which is caused by impaired blood flow to the leg muscles. […] In general, the goal of surgical treatment is to decompress (remove the pressure from) the nerve roots in the lumbar spine. If the compression results from a herniated disc, a microdiscectomy (a procedure that uses small incisions with a tiny video camera for viewing) may provide relief. In other cases, a laminectomy (removal of part of a bone) may be necessary. Our surgeons can determine the best treatment for each case.

• #67 Peripheral Arterial Occlusive Disease Treatment & Management: Approach Considerations, Smoking Cessation, Pharmacologic Therapy

  https://emedicine.medscape.com/article/460178-treatment

  Exercise plays a vital role in the treatment of claudication. Patients with PAOD reduce their daily walking because of the claudication pain they experience and their fear of causing further damage. Unfortunately, this leads to an increasingly sedentary lifestyle that is even more detrimental to their health. […] Patients who are treated medically should be seen every 4-6 months to assess the effects of therapy. Any changes in walking distance, smoking habits, eating habits, or exercise performance should be reviewed.

• #68 Claudication: Symptoms & Treatment

  https://my.clevelandclinic.org/health/diseases/21972-claudication

  Your provider may prescribe medications that: Lower your blood pressure (like ACE inhibitors), Lower your cholesterol (like statins), Lower your blood sugar level (like insulin), Prevent clotting to increase blood flow (like aspirin or clopidogrel), Open your arteries (like cilostazol). […] If medicines don’t work, your provider may want to do a minimally invasive treatment. They may use angioplasty to treat a narrow or blocked artery by using a catheter. A provider may also put a stent into an artery they open to help it stay that way. Another option is bypass surgery to reroute blood flow. Providers only use surgery in severe cases. […] Treatment for claudication gives many people a good prognosis (outlook). But it’s important to remember that peripheral artery disease (which causes claudication) is a lifelong condition. PAD progresses faster in some people than others. The expected length of your life depends on your specific situation. This includes any other diseases you have.

• #69 Intermittent Claudication: Causes, Symptoms, Treatments | Vein Centre

  https://veinreliever.com/intermittent-claudication-top-causes-symptoms-and-effective-treatments/

  Medications like cilostazol and pentoxifylline may help some patients increase their walking distance and improve symptoms. Cilostazol is noted for its antiplatelet and vasodilatory effects, aiding in improved blood circulation. […] When other treatments don’t work and the disease is severe, surgical interventions like bypass surgery and endovascular therapy may be required to restore blood flow. […] Regular exercise, particularly walking, is essential for lifestyle modification in claudication. Exercise training enhances muscle oxygen utilization, improving symptoms. […] A heart-healthy diet, rich in fruits, vegetables, and whole grains, is beneficial for managing intermittent claudication. […] Adherence to treatment and lifestyle modifications significantly influence prognosis. Following prescribed treatments and making necessary lifestyle changes can prevent progression and improve overall health outcomes. […] Intermittent claudication can lead to serious health issues, including critical limb ischemia, which has a poor prognosis. […] Intermittent claudication often indicates significant atherosclerosis and carries a heightened risk for cardiovascular events like heart attacks and strokes.

• #70 Intermittent Claudication & Peripheral Vascular Disease – Vascular Society of Aotearoa New Zealand

  https://vascular-society.nz/intermittent-claudication-pvd/

  Exercise can improve walking ability in patients with intermittent claudication by 150 per cent. Improvements in walking from an exercise programme appear to be better than any medication including cilostazol and may be equivalent in the long term to walking improvement from angioplasty. […] If your intermittent claudication symptoms are very severe, or if they do not improve, further treatment may be considered. […] The decision about surgery is usually one for you to make in discussion with your vascular specialist after they have explained the likelihood of success, and the risks involved.

• #71

  https://www.vascularsurg.com/claudication/

  Once the diagnosis of intermittent claudication has been clearly established, the first line of treatment is risk-factor modification. Patients who are above their ideal weight will frequently be able to walk farther simply by losing excess pounds. Cessation of cigarette smoking will prevent progression of arterial blockage and can improve walking distance. Control of diabetes, hypertension and elevated lipids frequently requires drug therapy managed by your primary physician. Exercise alone is an effective form of therapy. Studies have shown that a supervised exercise program, such as found at some hospitals, can significantly improve walking. The next line of therapy is drug treatment. Cilostazol, or Pletal, significantly improves the walking distance in 50-60% of patients. This medication interacts with some drugs and should NOT be given if you have known congestive heart failure. It takes 2-3 months to determine whether you are responding to Pletal. Common side effects are diarrhea, headache and palpitations.

• #72 Exploring treatment options for intermittent claudication | Lower Extremity Review Magazine

  https://lermagazine.com/article/exploring-treatment-options-for-intermittent-claudication

  Angioplasty plus exercise is better than either individual therapy, said Mary McDermott. […] The more time that has passed since your procedure, the more common is restenosis. […] With the exercise, you dont get immediate relief, but if you stick with it, at four to six weeks youll start seeing benefit. […] I think whether stenting adds anything to supervised exercise is still unanswered, Murphy said. […] But they should also get an exercise program, and the combination is one of the best approaches.

• #73 Intermittent Claudication: Symptoms & Treatment

  https://my.clevelandclinic.org/health/symptoms/22046-intermittent-claudication

  Surgery or minimally invasive procedures Procedures to restore blood flow may relieve or reduce the pain from intermittent claudication. Possible procedures include the following: Angioplasty: This is a minimally invasive procedure that uses a catheter to widen the artery. […] Claudication increases your risk for serious heart and circulatory problems. This is why treatment usually involves preventive measures to avoid those complications. […] Many of the at-home treatments for intermittent claudication can also help prevent it. While its not always possible to prevent it completely, it may be possible to delay when it develops. […] If you have intermittent claudication, early diagnosis and treatment can help you avoid or limit serious problems in the future.

• #74 Management of symptomatic peripheral artery disease: Claudication – UpToDate

  https://www.uptodate.com/contents/management-of-claudication-due-to-peripheral-artery-disease

  Management of symptomatic peripheral artery disease: Claudication […] The general management of the patient with claudication due to PAD is reviewed. […] The management of exertional leg pain from other causes of arterial obstruction (eg, aneurysm thrombosis, embolism), arterial compression (eg, popliteal entrapment syndrome), or musculoskeletal disorders (eg, lumbar spine stenosis, adductor bursitis, spine or hip osteoarthritis) differs from PAD. […] The following limb outcomes at five years demonstrate the overall low risk of progression for most patients with lower extremity claudication: Stable claudication – 70 to 80 percent. […] Algorithm for the management of claudication […] Benefit of supervised exercise therapy in claudication.

• #75 Intermittent Claudication: Causes, Symptoms, Treatments | Vein Centre

  https://veinreliever.com/intermittent-claudication-top-causes-symptoms-and-effective-treatments/

  Medications like cilostazol and pentoxifylline may help some patients increase their walking distance and improve symptoms. Cilostazol is noted for its antiplatelet and vasodilatory effects, aiding in improved blood circulation. […] When other treatments don’t work and the disease is severe, surgical interventions like bypass surgery and endovascular therapy may be required to restore blood flow. […] Regular exercise, particularly walking, is essential for lifestyle modification in claudication. Exercise training enhances muscle oxygen utilization, improving symptoms. […] A heart-healthy diet, rich in fruits, vegetables, and whole grains, is beneficial for managing intermittent claudication. […] Adherence to treatment and lifestyle modifications significantly influence prognosis. Following prescribed treatments and making necessary lifestyle changes can prevent progression and improve overall health outcomes. […] Intermittent claudication can lead to serious health issues, including critical limb ischemia, which has a poor prognosis. […] Intermittent claudication often indicates significant atherosclerosis and carries a heightened risk for cardiovascular events like heart attacks and strokes.

• #76 Patients with Claudication | Society for Vascular Surgery

  https://vascular.org/patients-and-referring-physicians/referring-physicians/who-refer/patients-claudication

  Claudication is defined as leg pain with walking that is relieved by rest. […] Initial management of Claudication consists of lifestyle modification, smoking cessation, targeted medical management, and exercise therapy. […] Patients should be referred to a vascular surgeon when their symptoms are severe or progress. […] Individuals whose lifestyle is limited due to Claudication may be candidates for intervention. […] Early referral and collaboration with a vascular surgeon can lead to better outcomes for each patient. […] Recommendations for the management of patients with symptoms of Claudication: While symptomatic patients should also be counseled to stop smoking, additional treatment strategies include: Patients should be prescribed an anti-platelet agent and a statin. First-line therapy should consist of a supervised exercise program with walking a minimum of three times per week (30-60 min/session) for at least 12 weeks. Early referral to a vascular surgeon is encouraged for initial management as well as consideration of revascularization based on the patients response to noninvasive therapies.

Zobacz więcej